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Abstract 
Carolight® is a transgenic maize variety that accumulates extraordinary levels of carotenoids, 
including those with vitamin A activity. The development of Carolight® maize involved the technical 
implementation of a novel combinatorial transformation method, followed by rigorous testing for 
transgene expression and the accumulation of different carotenoid molecules. Carolight® was 
envisaged as a way to improve the nutritional health of human populations that cannot access a 
diverse diet, but this ultimate humanitarian application can only be achieved after extensive testing 
for safety, agronomic performance and nutritional sufficiency. In this article, we chart the history of 
Carolight® maize focusing on its development, extensive field testing for agronomic performance 
and resistance to pests and pathogens, and feeding trials to analyze its impact on farm animals (and 
their meat/dairy products) as well as animal models of human diseases. We also describe more 
advanced versions of Carolight® endowed with pest-resistance traits, and other carotenoid-
enhanced maize varieties originating from the same series of initial transformation experiments. 
Finally we discuss the further steps required before Carolight® can fulfil its humanitarian objectives, 
including the intellectual property and regulatory constraints that lie in its path. 
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Introduction 
Carotenoids are organic pigments produced by photosynthetic organisms to absorb light energy 
during photosynthesis and to protect chlorophyll from damage (Armstrong and Hearst, 1996). The 
antioxidant activity of carotenoids is also beneficial to animals, but only a few arthropods can 
synthesize carotenoids de novo and all other animals must obtain these molecules in their diet. 
Carotenoids with unsubstituted β-ionone rings have vitamin A activity, i.e. they are converted into 
retinal and then into either retinol (by reduction) or retinoic acid (by oxidation). The four major 
carotenoids with vitamin A activity are β-carotene, α-carotene, β-cryptoxanthin and γ-carotene. 
These are collectively known as provitamin A (PVA) carotenoids and are regarded as essential dietary 
components. Other non-PVA carotenoids also perform specific and arguably essential roles in the 
body, e.g. lutein and zeaxanthin accumulate in the retinal macula where they function to absorb 
blue and near-ultraviolet light. The provision of adequate quantities of carotenoids in the diet is 
essential, but many staple foods lack sufficient amounts of carotenoids and vitamin A deficiency is 
therefore prevalent in developing countries that rely on predominantly cereal-based diets with little 
access to fresh fruit and vegetables.  
Carotenoids are synthesized by all plants and many bacteria – the biosynthesis pathway is shown in 
detail in Figure 1. The first committed step in carotenoid biosynthesis is the conversion of 
geranylgeranyl diphosphate (GGPP) into phytoene by phytoene synthase (PSY), and this is 
recognized as a major pathway bottleneck. Indeed, this is precisely the reason for the near complete 
lack of carotenoids in rice grains and in the South African elite white-endosperm maize inbred 
M37W, which has a central role in the development of high-carotenoid maize as discussed in detail 
below. Phytoene is desaturated and isomerized in several steps to form lycopene, but one bacterial 
enzyme (CRTI) can accomplish all these reactions. Lycopene is then cyclized at each end by lycopene 
β-cyclase (LYCB, bacterial equivalent CRTY) to form β-carotene, or at one end by lycopene ε-cyclase 
(LYCE) and at the other by LYCB to form α-carotene. Both α-carotene and β-carotene can be 
converted into downstream products by carotene hydroxylases, such as β-carotene hydroxylase 
(BCH) and carotenoid ε-hydroxylase. In the β-carotene pathway this yields β-cryptoxanthin, which is 
further converted by the same enzyme into zeaxanthin, whereas in the α-carotene branch the 
conversion yields lutein, the natural pathway endpoint. Zeaxanthin enters the xanthophyll cycle 
through the activity of zeaxanthin epoxidase yielding violaxanthin. A de-epoxidase can catalyze the 
back reaction (Farré et al., 2010b). Although higher plants synthesize different hydroxylated 
carotenoids they in general are not able to produce ketocarotenoids such as astaxanthin. An 
exception is Adonis species which accumulate astaxanthin in their petals.  
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The absence of carotenoids in rice grains has been addressed by the expression of two 
carotenogenic transgenes in the endosperm to generate Golden Rice, which accumulates β-
carotene: Zmpsy1 (maize phytoene synthase) and crtI (phytoene desaturase) from the bacterium 
Pantoea ananatis (formerly called Erwinia uredovora) (Paine et al., 2005).  In maize, we used M37W 
as a baseline because it only produces trace amounts of carotenoids in the endosperm. This variety 
is culturally preferred in sub-Saharan Africa over yellow maize varieties that produce moderate 
levels of non-PVA carotenoids and also provides a blank canvas to develop carotenoid-enriched 
varieties because the accumulation of different carotenoids is immediately apparent through the 
production of colored endosperm. 
 
Generation of high carotenoid maize varieties with different carotenoid profiles 
The path towards high-carotenoid biofortified maize began when we transformed M37W with 
multiple carotenogenic transgenes using standard novel combinatorial transformation procedure, in 
which immature maize embryos are bombarded with DNA-coated metal particles (Ramessar et al., 
2008). All plants were also transformed with the selectable marker bar, which encodes 
phosphinothricin acetyltransferase and confers herbicide tolerance for selection. The resulting 
library of transformants (Zhu et al., 2008) included a range of genotypes representing different 
combinations of up to five metabolic input transgenes, all under the control of endosperm-specific 
promoters: Zmpsy1, PacrtI (P. ananatis phytoene desaturase), Gllycb (Gentiana lutea lycopene β-
cyclase), Glbch (G. lutea β-carotene hydroxylase) and ParacrtW (Paracoccus sp. β-carotene ketolase). 
The plants showed a diverse spectrum of endosperm color phenotypes representing the effects of 
different combinations of transgenes superimposed on the endogenous carotenoid biosynthesis 
pathway (Figure 2). One of the resulting transformants carried Zmpsy1 and PacrtI, the first two 
genes in the carotenoid pathway, and the endosperm produced extraordinary levels of β-carotene 
(up to 60 μg/g DW). This became the first-generation Carolight® variety. Another was found to carry 
all five of the metabolic input transgenes in addition to the selectable marker. The inclusion of 
ParacrtW among the five transgenes meant that this was the first transgenic maize variety to 
produce ketocarotenoids (36 μg/g DW, including 4.46 μg/g DW astaxanthin). Other events were 
found to contain different combinations of two, three or four of the input transgenes in addition to 
the selectable marker. Second-generation experiments were carried out to increase the levels of 
astaxanthin by knocking down endogenous lycopene ε-cyclase expression in the M37W endosperm 
while introducing Zmpsy1, sBrcrtZ (synthetic Brevundimonas sp. SD212 β-carotene hydroxylase), and 
sCrbkt (synthetic truncated β-carotene ketolase from the alga Chlamydomonas reinhardtii) codon 
optimized for plants (Farré et al., 2016). The best-performing line in terms of astaxanthin production 
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(line BKT) was crossed with the high-oil NSL76 line to generate the hybrid NSL76-BKT which 
accumulated 45% of total seed carotenoids as astaxanthin, up to 17 μg/g DW (Farré et al., 2016). The 
combination of astaxanthin, starch and high oil content makes NSL76-BKT particularly suitable as a 
feed component, as discussed in more detail below. 
 
Agronomic performance in the greenhouse and field  
Novel crops created with enhanced traits should be tested against their near-isogenic wild-type 
counterparts under a variety of environmental conditions to ensure that performance (in this case 
the accumulation of carotenoids) is maintained in different environments that are likely to be 
encountered following commercial release. This is particularly important with transgenic crops 
because early development is restricted to greenhouse cultivation and rigorous field testing is 
therefore necessary to determine the impact of variable temperature, light intensity, humidity and 
weather in the field (collectively abiotic stress) as well as exposure to pests and diseases (collectively 
biotic stress). We therefore evaluated Carolight® plants under greenhouse and field conditions and 
compared the carotenoid content and accumulation in developing endosperm over time. We also 
measured endogenous carotenogenic gene expression during endosperm development. Minor 
differences in the endosperm carotenoid composition were measured during early development, 
but there were no significant differences when we compared the mature endosperm of plants from 
the greenhouse and field, in terms of either the total carotenoid content or the carotenoid profile 
(Zanga et al., in press).  
Conventional breeding and genetic engineering can affect performance traits such as yield and 
biomass accumulation in a positive (Subedi and Ma, 2007) or negative (Elmore et al., 2001a; 2001b) 
manner, or the effect may be neutral (Marra et al., 2004; Laserna et al., 2012). Carotenoid 
enrichment is a form of metabolic engineering, so it is possible that the precursors and energy 
directed towards the synthesis of carotenoids may result in a trade-off with other traits due to 
competition for resources. We therefore set up a field trial to compare performance of Carolight® 
and M37W over three years. We applied two fertilization regimes to both varieties (no fertilization 
and 150 kg nitrogen ha-1). There were no significant differences in yield between Carolight® and its 
isogenic line under either of the nitrogen treatments, nor was there any evidence of a significant 
nitrogen × genotype interaction (Zanga et al. in press). Furthermore, there were no significant 
genotypic differences in the leaf oxygen isotopic composition (δ18O) at any developmental stage, 
suggesting the two lines performed similarly in terms of stomatal control of water loss, which is an 
indicator of drought resistance (Cabrera-Bosquetet al., 2009). There was a significant difference in 
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δ18O between developmental stages in both genotypes regardless of the nitrogen treatment, which 
indicated greater stomatal control during flowering when crop water demand is highest. 
 
Resistance to pests and pathogens 
The major intended application of Carolight® is the provision of a nutritionally improved staple crop 
for human consumption, so it was important to introduce further traits into this variety to make it 
compatible with current maize cultivation practices and save pesticide application and consequent 
residues as much as possible. We therefore introduced the Bacillus thuringiensis (Bt) cry1Ac gene, 
which is widely used in commercial maize varieties to provide resistance against lepidopteran pests, 
particularly corn borers. Transgenic maize lines transformed with cry1Ac were produced from the 
M37W genetic background and the resulting plants were characterized to confirm transgene 
expression at the mRNA and protein levels, to ensure that the Bt toxin was produced at sufficient 
amounts for effective insect control. This resulted in the identification of an elite event which was 
crossed with homozygous Carolight® plants. The hybrid progeny were screened for the presence of 
both cry1Ac and the carotenogenic genes, and positive lines were self-pollinated to generate 
homozygous lines for field testing. Tests confirmed that the enhanced Carolight® plants expressing 
cry1Ac were protected from common lepidopteran maize pests such the European corn borer 
(Ostrinia nubilalis) and the Mediterranean corn borer (Sesamia nonagrioides) with similar rates of 
mortality compared to the commercial event MON810, which contains the related Bt gene cry1Ab 
(Zanga et al., in preparation).   
These trials were important because little is known about the effect of biofortified crops such as 
Carolight® on herbivore development and behavior. For example, surplus vitamin C in the diet of 
herbivorous insects can have both positive and negative effects, the latter including delayed growth, 
lower weight, lower fecundity and a shorter lifespan (Goggin et al., 2010). However, it is unknown 
whether the levels of vitamin A and other carotenoids affect insect pests and whether the current 
range of insecticidal transgenes would work in a crop that has been engineered to increase 
carotenoid levels in the endosperm. Carotenoids are used by insects as visual pigments in their body 
markings, as antioxidants, and for the synthesis of certain hormones, but the relationship between 
carotenoids in food and their functions in insects have not been investigated (Heath et al., 2013). 
The oxidative cleavage of carotenoids into volatile apocarotenoids is likely to affect insect behavior 
because these act as semiochemicals, some of which are attractive others repulsive (Caceres et al., 
2016). Such repellent effects may explain why the maize stem borer (S. nonagrioides) found 
7 
 
Carolight® plants less attractive as a place to lay eggs than isogenic control plants (Cruz and 
Eizaguirre, 2015).  
Several  experiments were therefore conducted to determine whether the higher levels of 
carotenoids in Carolight® affected the development of two maize pests: the abovementioned 
European corn borer, which penetrates the stalks and cobs but also feeds on leaves, and the 
armyworm moth (Mythimna unipuncta), which feeds mainly on the leaves. Larvae from both species 
were allowed to feed on Carolight® leaves or leaves from the near-isogenic M37W control for 14 
days, and three parameters were investigated: larval mortality, leaf consumption, and larval weight. 
The results were similar for both pest species. There were no significant differences in mortality 
after 14 days but both species consumed less leaf material when presented with the Carolight® line 
although this did not significantly affect larval weight. This was interesting because the direct 
measurement of carotenoid levels in the leaves revealed no differences in carotenoid content (the 
transgenes are expressed under the control of endosperm-specific promoters and carotenoid 
biosynthesis is only modulated in the endosperm). However, the Carolight® leaves were less 
pigmented than the M37W leaves suggesting a knock-on effect of carotenoid metabolism in the 
seeds which affects the leaves and, more specifically, how attractive they are to insect pests. This 
difference in pigmentation was not sufficient to cause a change in photosynthetic performance as 
reflected in grain yield (discussed in the previous section). The conclusion from these trials is 
therefore that the presence of additional carotenoids in the Carolight® variety per se does not 
change the mortality of major pest insects, but does result in the consumption of less leaf biomass at 
the larval stage. 
As well as the direct negative effects on plant health, the damage caused by insect pests also 
encourages the colonization of maize grains by filamentous fungi. Some of these opportunistic fungi 
produce mycotoxins, secondary metabolites that can cause illness in both humans and livestock. 
Maize seeds are often contaminated with fumonisins produced by Fusarium verticillioides and 
F. proliferatum, although other mycotoxins such as aflatoxins may be found alone or together with 
fumonisins in maize (Marín et al., 2013). Several studies have reported a significant reduction in pest 
damage, disease symptoms and fumonisin levels in maize hybrids that express Bt genes (Díaz-Gómez 
et al., 2015). However, the effect of carotenoids on mycotoxin contamination has not yet been 
studied in detail. 
The field tests were carried out for three consecutive seasons using M37W and Carolight® without 
the additional Bt trait (to allow us to test the effect of the carotenoids alone, in the absence of the 
known beneficial effects of Bt). The grain of both varieties was tested for the prevalence of fungal 
contamination and the accumulation of different mycotoxins. There were no significant differences 
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in the extent of fungal infection (expressed as the proportion of infected grains), and as expected 
the dominant genus in all three seasons was Fusarium and the most common species was 
F. verticillioides. Aspergillus species were not identified in any of the tested samples, and accordingly 
there was no sign of contamination with aflatoxins. Due to the presence of Fusarium spp. there was 
fumonisin contamination in both Carolight® and M37W, but the proportion of infected grains was 
substantially higher in the M37W variety (1.4-fold, 2.4-fold and 2-fold more in the 2013, 2014 and 
2015 seasons, respectively). It therefore seems likely that the more abundant carotenoids in the 
Carolight® grains either reduce the amount of damage caused by insects and thus limit the 
opportunity for fungal contamination (which would concur with the feeding assays discussed above), 
or the antioxidant activity of the carotenoids has a direct inhibitory effect on fungal growth, 
fumonisin biosynthesis or accumulation in maize plants. Indeed, both mechanisms may operate 
simultaneously (Díaz-Gómez et al., 2016). 
 
Animal feeding trials as a first step towards a human nutritional product 
As discussed above, Carolight® maize is envisaged as a technology-based solution to improve the 
range of micronutrients available to malnourished human populations. Therefore, in line with other 
novel crops, transgenic or otherwise, intended for commercial release Carolight® must be tested 
according to internationally established guidelines to ensure safety. The assessment of novel crops 
must include compositional analysis, laboratory animal feeding trials to test sub-chronic 
toxicity/allergenicity, and nutritional assessment (Kuiper et al., 2001; König et al., 2004; EFSA 2011a; 
2011b).  
Carolight® was initially tested in the laboratory to confirm its substantial equivalence to the near-
isogenic line M37W. Compositional analysis showed no nutritionally-relevant differences between 
Carolight® and M37W in terms of its major constituents, other than the intended modification of the 
carotenoid content (Arjó et al., 2012). This was followed by a 90-day sub-chronic toxicity study in 
mice, which was designed to address the consequences of repetitive exposure for a duration 
considered long enough to reveal the effects without confounding age-related effects (EFSA 2011a). 
During this feeding trial, mice reared on two nutritionally balanced diets identical in all respects 
apart from the presence of either Carolight® or M37W showed no differences in their rates of food 
consumption or body weight gain, which are generally recognized as broad indicators of health and 
wellbeing. This provided strong evidence that the consumption of Carolight® does not induce 
unintended nutritional effects. Similarly, there were no significant differences between the diet 
groups in terms of clinical observations, hematological parameters, biochemical markers and 
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absolute or relative changes in organ weight. In summary, Carolight® was found to be 
compositionally substantially equivalent to M37W and to satisfy current requirements to 
demonstrate the absence of sub-chronic toxicity (Arjó et al., 2012). No single animal model 
addresses all potential sources of toxicity (Gephart et al., 2001) but a positive outcome following a 
90-day sub-chronic toxicity test provides strong supporting evidence for safety (Ricroch, 2013). 
The beneficial effects of a carotenoid-rich diet are well known (Pérez-Massot et al., 2013) so the next 
step in the development of Carolight® was to investigate its effects as the primary dietary 
component in preclinical models of chronic diseases, beginning with its impact on insulin sensitivity 
in a mouse model of insulin resistance and obesity induced by a high-fat diet. Overweight and obese 
individuals carry a higher risk of type-2 diabetes (Pan et al., 2013; Breen et al., 2014). Studies in both 
experimental animal models and humans have shown that dietary fat composition influences insulin 
sensitivity, i.e. saturated fats promote high plasma insulin levels (a surrogate for lower insulin 
sensitivity) whereas unsaturated fats help to improve insulin sensitivity (Riccardi et al., 2004). 
Interestingly, several studies have shown that obese individuals often face malnutrition, in terms of 
vitamin A deficiency (Calder et al., 2011; Wolf, 2010; Gunanti et al., 2014). Insulin resistance can be 
reversed by lifestyle changes like the adoption of a healthy diet before the onset of overt diabetic 
symptoms, including the acquisition of sufficient vitamin A (Macotela et al., 2011). Obesity also 
increases the risk of several other chronic diseases, including hypercholesterolemia, 
hypertriacylglyceridemia, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), 
hypertension/stroke, bone disorders and certain forms of cancer (Greenberg and Obin, 2006). 
Preclinical tests indicated that the inclusion of Carolight® rather than M37W in the diet improved 
systemic glucose homeostasis and the LDL/HDL cholesterol ratio in obese mice by increasing the 
sensitivity of skeletal muscle and adipose tissue to glucose uptake. The mixture of carotenoids 
contained in the Carolight® endosperm matrix therefore appears to achieve health-promoting 
effects in obese mice, and the pathophysiological data from this study could facilitate the rational 
development of nutrition-based treatments for insulin resistance. Further experiments are required 
to determine the precise effects of Carolight® maize in this mouse model and the underlying 
mechanism (Arjó, 2014). 
Insulin resistance is usually associated with NAFLD, which includes hepatic macrovesicular steatosis 
with inflammation that can ultimately lead to cirrhosis and eventually hepatocellular carcinoma 
(Armstrong et al., 2014). The molecular pathophysiology of NAFLD remains unclear, but the most 
widely accepted theory involves an initial increase in triglyceride accumulation followed by 
enhanced cellular responses such as oxidative stress and the production of pro-inflammatory 
cytokines. Nutritional approaches have been considered for the prevention and treatment of NAFLD 
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and retinoic acid can prevent NAFLD (Amengual et al., 2010; Liu et al., 2015; Stefanska et al., 2012).  
Because pro-vitamin A carotenoids in the diet are converted into retinal by carotene dioxygenase, 
and from there either into retinol or retinoic acid, a further preclinical feeding trial was designed in 
which Carolight® maize was fed to mice haploinsufficient for the phosphatase and tensin homolog 
gene (PTEN), which causes them to develop NAFLD spontaneously. When these PTEN+/- mice were 
fed on Carolight® maize, lipid metabolism in the liver was modulated to reduce lipogenesis, resulting 
in a less severe NAFLD phenotype (Eritja et al., 2016). Although caution should be exercised when 
extrapolating these findings to humans, the study suggests that Carolight® maize could be developed 
as part of a combinational dietary intervention to reduce steatosis in patients genetically or 
phenotypically predisposed to NAFLD. 
 
Applications of Carolight® maize in agriculture 
Poultry production 
The typical commercial poultry diet based on maize and soybean does not supply sufficient 
carotenoids to produce the golden skin preferred by many consumers, and does not confer 
additional health benefits upon the animals. Vitamin A (in the form of retinol) and natural or 
synthetic pigments are routinely added to poultry feed, increasing the production costs (Castañeda 
et al., 2005). Carolight® maize was therefore evaluated as a replacement for carotenoid additives in 
a laboratory feeding trial using commercial broilers (Ross 308 males) fed on diets supplemented with 
58% Carolight® maize or M37W maize as a control (Nogareda et al., 2016). There were no 
differences between the diet groups in terms of growth, final body weight or the final weight of 
most organs. The exception was the bursa of Fabricius, a lymphoid gland located on the 
posterodorsal wall of the cloaca that regresses with sexual maturity but plays an important role in 
disease resistance. This was heavier in the birds fed on the diet containing Carolight® maize, but 
there were no histopathological abnormalities that would indicate a health problem. The CIELAB 
trichromatic system was used to quantify the lightness, redness and yellowness of pre-chilled meat 
and skin tissue from birds in both diet groups. This revealed significant differences in the color of the 
meat, skin and cutaneous structures such as the comb and the base of the feathers (Figure 3). 
Chickens raised on Carolight® maize were healthy and accumulated higher levels of bioavailable 
carotenoids in peripheral tissues, muscle, skin and fat, and also more retinol in the liver, than birds 
fed on control maize diets. A second similar trial was conducted under farm environment conditions. 
The results were identical to those we obtained in the initial laboratory trial (Nogareda et al., 2016).  
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Having confirmed that the Carolight® maize diet was safe in broilers and promoted carotenoid 
accumulation in many different organs and structures, a further trial was carried out incorporating a 
challenge with Eimeria tenella, one of several protozoan parasites that cause coccidiosis, an 
important disease in commercial broiler farms. Two groups of animals were fed on each of the two 
diets used in the first and second trials described above, resulting in four experimental groups in 
total. One group on each diet was challenged orally with an E. tenella inoculum of 24.3 × 104 
sporulated oocysts (Houghton strain). During the trial, the birds were visually inspected for foot pad 
dermatitis and digital ulcers. After the trial, the post-challenge fecal oocyst counts were evaluated, 
and the birds were dissected for gross necropsy and the analysis of intestinal lesions. The birds on 
the Carolight® diet challenged with the parasite suffered milder symptoms than those on the M37W 
diet and the fecal oocyst counts were significantly lower. The incidence of foot pad dermatitis and 
digital ulceration was significantly lower in animals fed on Carolight® diet in both the challenged and 
non-challenged groups, suggesting that the high-carotenoid diet protects against lesions in both the 
presence and absence of coccidiosis. The incorporation of Carolight® maize into broiler diets 
therefore not only improves the carotenoid levels in skin and meat, but also provides a cost-effective 
strategy for the protection of broilers against coccidiosis without the need for carotenoid additives 
(Nogareda et al., 2016).  
 
Egg production 
Synthetic carotenoids or carotenoid additives such as marigold and red pepper are not only added to 
broiler diets but also to the feed provided to laying hens in order to achieve the characteristic 
yellow-orange color of egg yolks desired by consumers. As discussed above for broilers, the use of 
biofortified maize varieties producing additional carotenoids would provide a more cost-effective 
solution because no additives would be required. However, it is unclear how carotenoids are 
mobilized from the feed to the eggs and whether certain carotenoids are more likely to be deposited 
in the egg yolk or diverted to the tissues in the hen. For this reason, feeding trials were carried out 
using not only the Carolight® variety which is rich in carotenoids, but also the abovementioned BKT 
variety which is rich in ketocarotenoids and produces a darker red-orange endosperm than 
Carolight® maize. Hens fed on diets supplemented with either Carolight® or BKT were compared to 
those fed on the M37W variety and a commercial diet of yellow maize with added retinol, typical in 
the poultry industry. The hens were assessed for their productivity and egg quality parameters 
during the trial, and were then dissected for gross necropsy and to investigate the fate and 
distribution of carotenoids in specific tissues (including the eggs). Hens in all four diet groups were 
initially fed on the M37W diet for 12 days to deplete the carotenoid content of their tissues and 
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eggs, and then switched to the four experimental diets for the remaining 20 days. The two 
biofortified maize diets had the lowest feed conversion ratio (weight of feed consumed/weight of 
eggs produced) which means that less feed was consumed to produce the same weight of eggs, i.e. 
the biofortified diets were nutritionally more efficient. There were no differences among the diet 
groups in egg quality parameters such as average egg weight, breaking strength, albumen height, 
Haugh units or shell thickness, but substantial differences in terms of yolk color based on the DSM 
scale. Before the trial, the hens produced eggs with an average yolk DSM value of just below 10. This 
fell to 1.25 after 12 days on the M37W diet as the carotenoids stored by the hens became depleted. 
After 20 days on the four different experimental diets, eggs laid by hens fed on diets supplemented 
with BKT and Carolight® maize had the highest DSM values (11.38 and 10.08, respectively) compared 
to eggs laid by hens fed on the commercial and M37W-based diets (4.22 and 1.25, respectively) as 
shown in Figure 4 (Moreno et al., submitted). 
One of the key results from this feeding trial was data concerning the distribution of different 
carotenoids in the feed, the hens and the eggs. The four diets (Carolight®, BKT, commercial maize 
and M37W) had total carotenoid levels of 31.05, 13.81, 9.22 and 0.84 µg/g fd (freeze-dried tissue), 
respectively, whereas the total carotenoid content of the eggs from the same diet groups was 57.5, 
26.18, 11.54 and 1.81 µg/g fd, respectively. These results suggested that specific carotenoids are 
favorably transferred to the eggs against a concentration gradient as they accumulate at higher 
levels in the egg compared to the initial concentration in the feed. The enhancement was most 
noticeable in the maize diets without retinol, including M37W which only contains low levels of 
carotenoids (Moreno et al., 2016). Interestingly, a more detailed analysis of the distribution of 
different carotenoids revealed that PVA carotenoids were diverted on their way to the egg whereas 
non-PVA carotenoids accumulated in the egg against the concentration gradient, doubling (lutein) or 
even tripling (zeaxanthin) the initial concentration in the feed. The hens appear to sequester PVA 
carotenoids from the maize, as well as the retinol provided in the commercial diet, whereas non-PVA 
carotenoids such as lutein and zeaxanthin are specifically directed to the yolk even if the hen tissues 
are relatively depleted. The PVA carotenoids appear to be converted into retinol and stored in the 
liver, because the liver retinol levels in the four diets (Carolight®, BKT, commercial maize and M37W) 
were 1397, 1790, 1454 and 380 µg/g fd, respectively, even though the commercial diet was directly 
supplemented with retinol. The provision of PVA carotenoids in biofortified maize therefore appears 
to be a more efficient way of providing hens with retinol than giving them retinol supplements, 
which may reflect the indirect manner in which PVA carotenoids are converted to retinol via retinal. 
Even so, the eggs produced by hens on the Carolight® diet contained more of the PVA carotenoids β-
carotene and β-cryptoxanthin than the other diet groups. Uniquely, the eggs in the BKT diet group 
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accumulated ketocarotenoids, mainly astaxanthin, the deep red color of which explains the higher 
DSM score of the eggs in the BKT diet group despite the higher total carotenoid levels in the 
Carolight® diet group (Moreno et al. submitted). 
 
Swine production 
The National Research Council daily recommended intake of vitamin A for swine varies from 1750 IU 
in starters (from weaning to 25 kg) to 4000 IU in finishers (from 80 kg to market weight) (NRC, 2012). 
Swine convert β-carotene and other PVA carotenoids into vitamin A with only about ~30% of the 
efficiency seen in rats or poultry (McDowell, 2000). Dietary supplements are therefore necessary to 
prevent vitamin A deficiency, and feed manufacturers are authorized to recommend retinol 
supplements at 5 times the NRC levels (Feed additives regulation EU 2015/724). Maize is a major 
feed grain and a standard component of swine diets as a source of digestible energy. Carotenoid-
biofortified maize varieties such as Carolight® could therefore be useful in swine nutrition by 
providing both a source of calories and carotenoids.  
In a pilot experiment at the CEP Consortium Swine Research Centre facilities (Lleida, Spain) finishing 
pigs were reared on diets incorporating either 20% Carolight® maize or an equivalent amount of 
M37W. Two groups of 16 pigs were fed ad libitum on the two diets from 160 to 190 days of age. 
There were no significant differences in any of the production traits that were monitored during the 
trial (live weight, feed intake, average weight gain or feed conversion rate) agreeing with the 90-day 
exposure experiment in mice (Arjó et al., 2012). At 190 days, the pigs were slaughtered and samples 
of liver, subcutaneous fat and muscle (longissimus dorsi and gluteus medius) were collected to 
determine the fat content and composition. The livers from the Carolight® diet group contained 
three times as much all-trans retinoic acid as livers from the M37W group, and both the livers and 
the muscles from the Carolight® group contained 15-55% less fat than the control group. The 
subcutaneous fat was enriched for mono-unsaturated fatty acids (48.0% in the Carolight® group, 
46.6% in the M37W group) particularly oleic acid (42.1% in the Carolight® group, 40.5% in the M37W 
group) mainly at the expense of polyunsaturated fatty acids. In contrast, the liver fat in the 
Carolight® group was depleted for monounsaturated fatty acids (18.4% in the Carolight® group, 
22.4% in the M37W group) but accumulated more polyunsaturated fatty acids (46.8% in the 
Carolight® group, 42.9% in the M37W group). The lower fat content in Carolight®-fed pigs is 
consistent with the general finding that retinoic acid can prevent NAFLD in mice (Amengual et al., 
2010; Eritja et al., 2016), which is supporting evidence for a favorable effect also in humans. 
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In terms of swine production, these results show that the inclusion of carotenoid-rich biofortified 
maize reduces the need for vitamin A supplements. The loss of intramuscular fat and lower 
polyunsaturated fatty acids in the subcutaneous fat has two important implications for meat quality: 
first, the depletion of intramuscular fat may affect the eating quality of pork because there is a 
positive relationship between intramuscular fat and sensory attributes; second, the depletion of 
polyunsaturated fatty acids reduces the risk of rancidity, particularly in processed products such as 
dry-cured hams and salami.  
 
Aquaculture 
Astaxanthin is the most expensive feed ingredient used in salmon and trout farming but its inclusion 
is necessary to achieve the aesthetic pink flesh color preferred by consumers. Most of the 
astaxanthin used in salmon and trout farming is synthetic (Moretti et al., 2006; Berman et al., 2015). 
There are only a few biological sources, such as the bacterium Paracoccus carotinifaciens, the alga 
Haematococus pluvialis and the fungus Xanthophyllomyces dendrorhous, and their availability is 
limited (Ambati et al., 2014). Therefore, biological production is not sufficient to supply the global 
astaxanthin market, which has a current annual demand of 300 tons (Research and Markets, 2015; 
Berman et al., 2015). Astaxanthin produced in maize line NSL76-BKT has therefore been evaluated as 
replacement for synthetic astaxanthin in salmon and trout feed, in a feeding trial lasting 7 weeks 
(Breitenbach et al., 2016). The extracted raw material was mostly non-esterified astaxanthin, with 12% 
adonixanthin and 2% zeaxanthin as additional carotenoids. Isomeric analysis confirmed the exclusive 
presence of the 3S, 3'S astaxanthin enantiomer. The incorporation of the oily astaxanthin 
preparation into trout feed delivered 7 mg/kg astaxanthin in the final feed formulation for the first 
half of the trial, and 72 mg/kg in the last half of the trial. The pigmentation of the trout fillets was 
quantified by assessing hue values using a DSM color meter (Figure 5) and the level of astaxanthin 
determined by HPLC was 3.5 μg/g FDW. The comparison of relative carotenoid levels in the feed, 
fillets and feces revealed that zeaxanthin and adonixanthin were absorbed more efficiently than 
astaxanthin (Breitenbach et al., 2016).  
 
Intellectual property and freedom to operate 
Before Carolight® seed can be introduced into agricultural systems, any issues relating to intellectual 
property in developed and developing countries must be addressed. Patents that might impact 
Carolight® research, development and release in target countries must be identified in order to 
avoid any infringement of existing intellectual property rights. Licenses may need to be negotiated 
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to allow the introduction of Carolight® into agricultural systems. A freedom to operate (FTO) analysis 
was therefore carried out to identify granted patents and patent applications that might affect its 
commercialization and distribution. Although the FTO analysis was carried out by scientists rather 
than legal experts, thus limiting its legal value, the preliminary FTO conclusions nevertheless provide 
an inexpensive initial basis for a more formal FTO Opinion, which must be prepared by legally 
trained professionals. By deconstructing the Carolight® product into its individual components, 
including materials such as genetic elements, and processes such as genetic transformation 
(Kowalski and Kryder, 2002; Kryder et al., 2000), 26 patents or patent families that potentially affect 
FTO were identified (Zanga et al., 2016). These patents were identified based only on content, 
without screening to determine whether the patents had expired or whether the protection had 
been sought or granted in Europe/Spain (place of development) or South Africa/India (principal 
places of intended deployment). Further analysis, considering the expiry dates and geographical 
validity, reduced the number of relevant patent family members requiring more detailed assessment 
to three: PCT application WO2001088169 assigned to Monsanto Technology LLC (carotenogenic 
genes), and EP2297189 assigned to Athenix Corp and EP2087120 assigned to Pioneer Hi-Bred (both 
referring to Bt insecticidal genes). These patents should be analyzed by legal experts to determine 
whether the production and/or commercialization of Carolight® could infringe any intellectual 
property rights related to these patents. If such infringements are identified, appropriate licenses 
will need to be negotiated with the owners of protected materials and processes.  
 
Regulatory constraints 
Carolight® maize is a genetically-modified (GM) crop and the principal regulatory constraints 
therefore reflect this status. Despite the continuous growth in GM agriculture since the first 
commercial releases in 1995 and the widespread acknowledgements of its benefits (James, 2015), 
the regulatory framework for the development of new GM varieties has become increasingly difficult 
to negotiate, mainly reflecting the pernicious effect of public and media hostility on the political 
handling of GM technology (Ramessar et al., 2009). There is also a stark difference between the 
regulation of GM crops in North America and the European Union, with most countries in the world 
adopting a regulatory framework that is aligned with either one or the other. The North American 
system is product based, and risk assessment is based on the concept of substantial equivalence. 
This means that the weight of evidence must show that a new product is dangerous before 
commercial development can be stopped. In contrast, the EU system is process based, and risk 
assessment is based on the precautionary principle. This means that identical crops developed by 
conventional breeding and biotechnology would be regulated differently due to the different 
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processes involved, and the weight of evidence is required to show that a new product is safe before 
commercial development can be approved. The paradoxes inherent in the EU system have been 
widely discussed (Masip et al., 2012) and the absence of science-based reasoning has resulted in a 
system of completely disharmonious and incompatible regulations at the global level and even 
between different Member States within the EU (Ramessar et al., 2010). When the complexity of 
trade agreements is layered on top of this, absurd situations arise such as countries banning the 
cultivation of GM crops but being legally obliged to import the same products grown abroad. In 
practical terms, this means that GM crops developed for humanitarian reasons are not only held up 
by IP constraints but also by the inconsistent regulatory framework, particularly given that many 
developing countries follow the EU system (Farré et al., 2010a; 2011). The cost of development must 
therefore include a substantial budget for regulatory affairs that dwarfs the costs of developing the 
actual product, making it very difficult for the technology to fulfil its promise (Berman et al., 2013; 
Yuan et al., 2011). 
   
Conclusions 
Carolight® maize has been developed as an efficient and economical vehicle to improve the 
nutritional health of human populations that cannot access a diverse diet. As well as providing 
essential nutrients in the form of PVA carotenoids, a carotenoid-enriched diet also provides 
numerous health benefits due to the general antioxidant activity of these pigments, which therefore 
have a positive effect on the outcome of several chronic diseases and infections exacerbated by 
oxidative stress. The use of animal diets based on carotenoid-enriched maize not only reduces costs 
by removing the need for artificial additives, but also protects the animals from stress and disease, 
and passes the benefits of carotenoid-rich meat and dairy products to humans. The carotenoids 
embedded in the matrix of the maize endosperm are also assimilated more efficiently than the same 
nutrients supplied as extracts or retinol supplements. These benefits do not attract a penalty in 
terms of agronomic performance and indeed Carolight® even appears to be more resistant to insect 
pests and mycotoxigenic fungi than its near-isogenic counterpart. The benefits of Carolight® and 
other carotenoid-enriched maize varieties such as BKT nevertheless will be challenging to realize 
without careful negotiation of the IP landscape and also the funding necessary to address an 
increasingly torturous regulatory system. 
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Figure 1. The extended carotenoid biosynthesis pathway in plants (Farré al., 2010). The precursor for the first 
committed step in the pathway is GGPP (geranylgeranyl pyrophosphate), which is converted into phytoene by 
phytoene synthase (PSY, CrtB). GGPP is formed by the condensation of IPP (isopentenyl pyrophosphate) and 
DMAPP (dimethylallyl pyrophosphate), which are derived predominantly from the plastidial MEP 
(methylerythritol 4-phosphate) pathway as shown in the upper part of the figure. The pathway is linear until 
lycopene, involving three steps catalyzed by separate enzymes in plants but by the single, multifunctional 
enzyme CrtI in bacteria. Lycopene is the branch point for the α- and β-carotene pathways, which usually end at 
lutein and zeaxanthin, respectively, through the expression of β-carotene hydroxylases (arrows with circles). 
An elaborated ketocarotenoid pathway can be introduced by expressing β-carotene ketolases (arrows with 
diamonds) because these compete for substrates with β-carotene hydroxylases and generate diverse products. 
Other abbreviations: GA3P, glyceraldehyde 3-phosphate; DXP, 1-deoxy-D-xylulose 5-phosphate; DXS, DXP 
synthase; DXR, DXP reductoisomerase; IPI, IPP isomerase; GGPPS, GGPP synthase; PDS, phytoene desaturase; 
ZDS, ζ-carotene desaturase; CRTISO, carotenoid isomerase; LYCB, lycopene β-cyclase; LYCE, lycopene ε-cyclase; 
HydE, carotene ε-hydroxylase. 
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Figure 2. Seven different phenotypes based on endosperm color were obtained by combinatorial nuclear 
transformation (Zhu et al., 2008). The five carotenogenic genes Zmpsy1, PacrtI, Gllycb, Glbch and ParacrtW 
were introduced into M37W resulting in five genotypes, including Ph-3 (Zmpsy1 + PacrtI) which became 
Carolight®. 
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Figure 3. Morphological comparison of chickens fed on the M37W control diet (left images in all panels) and 
the Carolight® diet (right images in all panels) showing carotenoid accumulation in the skin and cutaneous 
structures such as the beak, crest, eyelids, and at the base of feathers (Nogareda et al., 2016). 
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Figure 4. Yolks from eggs laid by hens fed on four experimental diets (from left to right: commercial diet and 
diets supplemented with BKT, Carolight® and M37W maize, respectively) compared to the DSM color scale 
(Moreno et al., 2016).  
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Figure 5. Trout fillets compared using the DSM scale for astaxanthin. From left to right: 0 = no astaxanthin in 
the feed; COM = commercial feed containing synthetic astaxanthin (CAROPHYLL); BKT = feed supplemented 
with BKT maize (Breitenbach et al., 2016).  
 
